MedPath
FDA Approval

ERTAPENEM SODIUM

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
NorthStar RxLLC
DUNS: 830546433
Effective Date
December 28, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ertapenem(1 g in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Gland Pharma Limited

NorthStar RxLLC

858971074

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ERTAPENEM SODIUM

Product Details

NDC Product Code
16714-889
Application Number
ANDA212040
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
December 28, 2023
ErtapenemActive
Code: 2T90KE67L0Class: ACTIMQuantity: 1 g in 1 1
Sodium BicarbonateInactive
Code: 8MDF5V39QOClass: IACT
Sodium HydroxideInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath